Previous studies have also reported high expression of PTTG3P in breast cancer and it has been found that PTTG3P expression is inversely correlated with estrogen receptor (ER) and progesterone receptor (PR) status, and high expression of PTTG3P is associated with poor prognosis of breast cancer [26]. This evidence concerns the gene ESR1 and breast cancer.